Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS-131 (S-equol) on Vasomotor Symptoms in Menopausal Patients
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2014
At a glance
- Drugs AUS 131 (Primary)
- Indications Menopausal syndrome; Vasomotor symptoms
- Focus Therapeutic Use
- Sponsors Ausio Pharmaceuticals
- 07 Apr 2014 Primary endpoint has been changed as as reported by ClinicalTrials.gov record.
- 06 Feb 2012 Actual end date (November 2011) added as reported by ClinicalTrials.gov.
- 06 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.